Advertisements


Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update

Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaMar 15th, 2019

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., March 18, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (NASDAQ:CPRX), a biopharmaceutical compa.....»»

Category: earningsSource: benzingaMar 18th, 2019

Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update

Oraxol Phase III clinical trial in metastatic breast cancer fully enrolled Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting A numb.....»»

Category: earningsSource: benzingaMar 11th, 2019

Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

SAN DIEGO, March 1, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM) ("Evofem" or the "Company"), a clinical stage biopharmaceutical company, today reported financial results for the three- and twelve- month periods ended.....»»

Category: earningsSource: benzingaMar 1st, 2019

Intec Pharma Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Update

JERUSALEM, Feb. 27, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces financial results for the fourth quarter and year ended December 31.....»»

Category: earningsSource: benzingaFeb 27th, 2019

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

SINGAPORE, March 22, 2019 (GLOBE NEWSWIRE.....»»

Category: earningsSource: benzingaMar 22nd, 2019

Opiant Pharmaceuticals, Inc. Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals, Inc. Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaMar 21st, 2019

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results

REDWOOD CITY, Cali.....»»

Category: earningsSource: benzingaMar 18th, 2019

Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaMar 14th, 2019

Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaMar 13th, 2019

Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

Annual Product Revenues Up 54% SOUTH ORANGE, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performa.....»»

Category: earningsSource: benzingaMar 12th, 2019

Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update

Eloxx announces the hiring of Dr. Susan Schneider as SVP Ophthalmology to lead the development of its rare inherited retinal disease programs Abstract acce.....»»

Category: earningsSource: benzingaMar 8th, 2019

Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaMar 1st, 2019

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the deve.....»»

Category: earningsSource: benzingaFeb 27th, 2019

CSI Compressco LP Announces Fourth Quarter And Full Year 2018 Results And Provides Update To 2019 Total Year Financial Guidance

THE WOODLANDS, Texas, Feb. 27, 2019 /PRNewswire/ -- CSI Compressco LP ("CSI Compressco" or the "Partnership") (NASDAQ:CCLP) today announced fourth quarter and full year 2018 consolidated financial.....»»

Category: earningsSource: benzingaFeb 27th, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»

Category: earningsSource: benzingaDec 13th, 2018

AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2018

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Tech.....»»

Category: earningsSource: benzingaSep 10th, 2018

Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update

Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaAug 23rd, 2018

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update Phase 2b Results for Topical Ocular Reproxalap in Dry Eye Disease Expected in Late Third Quarter or Early Fourth Quarter 2018 Cli.....»»

Category: earningsSource: benzingaAug 9th, 2018

Myovant Provides Corporate Update and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2018

Myovant Provides Corporate Update and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2018 - On track for top-line results from all relugolix Phase 3 clinical studies during 2019 - E.....»»

Category: earningsSource: benzingaJun 7th, 2018

Cheetah Mobile Announces Fourth Quarter and Full Year 2018 Unaudited Consolidated Financial Results

Cheetah Mobile Announces Fourth Quarter and Full Year 2018 Unaudited Consolidated Financial Results.....»»

Category: earningsSource: benzinga41 min. ago